SMAD1 and type 2 diabetes mellitus: Accordingly, the down-regulation of BMPR1B1b by RNAi technology inhibited the phosphorylation and nuclear translocation of its downstream p-smad1/5/9 and reduced the expression of osteogenic genes, thus decreasing vascular calcification in T2D mice.